logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Anna-Maria Fink

University of Cologne
H指数:28
被引数:3,921

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MRD-guided zanubrutinib, venetoclax, and obinutuzumab in relapsed CLL: primary end point analysis from the CLL2-BZAG trial

MRD指导下的zanubrutinib、venetoclax和obinutuzumab在复发性CLL中的应用：CLL2-BZAG试验的主要终点分析

BLOOD
IF23.1
2025-01-301
PRE
Fuerstenau, Moritz; Robrecht, Sandra; Schneider, Christof; Tausch, Eugen; Giza, Adam; Ritgen, Matthias; Bittenbring, Joerg; Hebart, Holger; Schoettker, Bjoern; Illert, Anna Lena; Graeven, Ullrich; Stoltefuss, Andrea; Heinrich, Bernhard; Eckert, Robert; Fink, Anna; Stumpf, Janina; Fischer, Kirsten; Al-Sawaf, Othman; Simon, Florian; Kleinert, Fanni; Weiss, Jonathan; Kreuzer, Karl-Anton; Schilhabel, Anke; Brueggemann, Monika; Langerbeins, Petra; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael; Cramer, Paula
Bendamustine, followed by obinutuzumab and idelalisib in chronic lymphocytic leukemia (CLL2-BCG): Final analysis of a multicenter, open-label phase-II-trial
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2024-04-050
OAAI
Cramer, Paula; von Tresckow, Julia; Fink, Anna-Maria; Robrecht, Sandra; Giza, Adam; Tausch, Eugen; Mueller, Lothar; Knauf, Wolfgang; Zingerle, Matthias; Al-Sawaf, Othman; Langerbeins, Petra; Fischer, Kirsten; Kreuzer, Karl-Anton; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael
Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial
NATURE MEDICINE
IF50
2023-12-0914
OAAI
Al-Sawaf, Othman; Ligtvoet, Rudy; Robrecht, Sandra; Stumpf, Janina; Fink, Anna-Maria; Tausch, Eugen; Schneider, Christof; Boettcher, Sebastian; Mikusko, Martin; Ritgen, Matthias; Schetelig, Johannes; von Tresckow, Julia; Vehling-Kaiser, Ursula; Gaska, Tobias; Wendtner, Clemens Martin; Chapuy, Bjoern; Fischer, Kirsten; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Staber, Philipp; Niemann, Carsten; Hallek, Michael; Eichhorst, Barbara
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia
NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2023-05-11124
PRE
Eichhorst, Barbara; Niemann, Carsten U.; Kater, Arnon P.; Fuerstenau, Moritz; von Tresckow, Julia; Zhang, Can; Robrecht, Sandra; Gregor, Michael; Juliusson, Gunnar; Thornton, Patrick; Staber, Philipp B.; Tadmor, Tamar; Lindstrom, Vesa; da Cunha-Bang, Caspar; Schneider, Christof; Poulsen, Christian B.; Illmer, Thomas; Schoettker, Bjoern; Noesslinger, Thomas; Janssens, Ann; Christiansen, Ilse; Baumann, Michael; Frederiksen, Henrik; van der Klift, Marjolein; Jaeger, Ulrich; Leys, Maria B. L.; Hoogendoorn, Mels; Lotfi, Kourosh; Hebart, Holger; Gaska, Tobias; Koene, Harry; Enggaard, Lisbeth; Goede, Jereon; Regelink, Josien C.; Widmer, Anouk; Simon, Florian; De Silva, Nisha; Fink, Anna-Maria; Bahlo, Jasmin; Fischer, Kirsten; Wendtner, Clemens-Martin; Kreuzer, Karl A.; Ritgen, Matthias; Brueggemann, Monika; Tausch, Eugen; Levin, Mark-David; van Oers, Marinus; Geisler, Christian; Stilgenbauer, Stephan; Hallek, Michael
Obinutuzumab, acalabrutinib, and venetoclax, after an optional debulking with bendamustine in relapsed or refractory chronic lymphocytic leukaemia (CLL2-BAAG) a multicentre, open-label, phase 2 trial
LANCET HAEMATOLOGY
IF17.7
2022-10-019
PRE
Cramer, Paula; Furstenau, Moritz; Robrecht, Sandra; Giza, Adam; Zhang, Can; Fink, Anna-Maria; Fischer, Kirsten; Langerbeins, Petra; Al-Sawaf, Othman; Tausch, Eugen; Schneider, Christof; Schetelig, Johannes; Dreger, Peter; Bottcher, Sebastian; Kreuzer, Karl-Anton; Schilhabel, Anke; Ritgen, Matthias; Bruggemann, Monika; Kneba, Michael; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael
Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial
LEUKEMIA
IF13.4
2022-06-254
OAAI
von Tresckow, Julia; Cramer, Paula; Robrecht, Sandra; Langerbeins, Petra; Fink, Anna-Maria; Al-Sawaf, Othman; Fuerstenau, Moritz; Illmer, Thomas; Klaproth, Holger; Tausch, Eugen; Ritgen, Matthias; Fischer, Kirsten; Wendtner, Clemens-Martin; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Boettcher, Sebastian; Eichhorst, Barbara F.; Hallek, Michael
Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
HEMASPHERE
IF14.6
2022-06-012
OAAI
Kutsch, Nadine; Pallasch, Christian; Decker, Thomas; Hebart, Holger; Chow, Kai Uwe; Graeven, Ullrich; Kisro, Jens; Kroeber, Alexander; Tausch, Eugen; Fischer, Kirsten; Fink, Anna-Maria; Wendtner, Clemens-Martin; Ritgen, Matthias; Stilgenbauer, Stephan; Zhang, Danjie; Li, Biao; Jurgensmeier, Juliane M.; Rajakumaraswamy, Nishanthan; Bhargava, Pankaj; Hallek, Michael; Eichhorst, Barbara
Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
HEMASPHERE
IF14.6
2022-04-0110
OAAI
Kutsch, Nadine; Pallasch, Christian; Tausch, Eugen; Boehme, Volkmar; Ritgen, Matthias; Liersch, Ruediger; Wacker, Alexander; Jacobs, Georg; Trappe, Ralf Ulrich; Dreger, Peter; Fischer, Kirsten; Fink, Anna-Maria; Stilgenbauer, Stephan; Zhai, Shuyan; Li, Biao; Jurgensmeier, Juliane M.; Rajakumaraswamy, Nishanthan; Bhargava, Pankaj; Hallek, Michael; Eichhorst, Barbara F.
Bendamustine followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia: primary endpoint analysis of a multicenter, open-label, phase II trial (CLL2-BIO)
HAEMATOLOGICA
IF7.9
2020-02-2715
OAAI
Cramer, Paula; von Tresckow, Julia; Robrecht, Sandra; Bahlo, Jasmin; Furstenau, Moritz; Langerbeins, Petra; Pflug, Natali; Al-Sawaf, Othman; Heinz, Werner J.; Vehling-Kaiser, Ursula; Durig, Jan; Tausch, Eugen; Hensel, Manfred; Sasse, Stephanie; Fink, Anna-Maria; Fischer, Kirsten; Kreuzer, Karl-Anton; Boettcher, Sebastian; Ritgen, Matthias; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael
Early treatment with FCR versus watch and wait in patients with stage Binet A high-risk chronic lymphocytic leukemia (CLL): a randomized phase 3 trial
LEUKEMIA
IF13.4
2020-02-1855
OAAI
Herling, Carmen D.; Cymbalista, Florence; Gross-Ophoff-Mueller, Carolin; Bahlo, Jasmin; Robrecht, Sandra; Langerbeins, Petra; Fink, Anna-Maria; Al-Sawaf, Othman; Busch, Raymonde; Porcher, Raphael; Cazin, Bruno; Dreyfus, Brigitte; Ibach, Stefan; Lepretre, Stephane; Fischer, Kirsten; Kaiser, Florian; Eichhorst, Barbara; Wentner, Clemens-Martin; Hoechstetter, Manuela A.; Doehner, Hartmut; Leblond, Veronique; Kneba, Michael; Letestu, Remi; Boettcher, Sebastian; Stilgenbauer, Stephan; Hallek, Michael; Levy, Vincent
Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy
LEUKEMIA
IF13.4
2019-11-147
PREAI
Fuerstenau, Moritz; Hopfinger, Georg; Robrecht, Sandra; Fink, Anna-Maria; Al-Sawaf, Othman; Langerbeins, Petra; Cramer, Paula; Von Tresckow, Julia; Maurer, Christian; Kutsch, Nadine; Hoechstetter, Manuela; Dreyling, Martin; Lange, Elisabeth; Kneba, Michael; Stilgenbauer, Stephan; Doehner, Hartmut; Hensel, Manfred; Kiehl, Michael G.; Jaeger, Ulrich; Wendtner, Clemens-Martin; Goede, Valentin; Fischer, Kirsten; von Bergwelt-Baildon, Michael; Eichhorst, Barbara; Hallek, Michael; Theurich, Sebastian
Mode of progression after first line treatment correlates with outcome of chronic lymphocytic leukemia (CLL)
AMERICAN JOURNAL OF HEMATOLOGY
IF9.9
2019-07-084
OAAI
Al-Sawaf, Othman; Bazeos, Alexandra; Robrecht, Sandra; Bahlo, Jasmin; Gower, Craig; Fink, Anna-Maria; Tresckow, Julia; Cramer, Paula; Langerbeins, Petra; Kutsch, Nadine; Humphrey, Kathryn; Fingerle-Rowson, Guenter; Stilgenbauer, Stephan; Wendtner, Clemens-Martin; Fischer, Kirsten; Eichhorst, Barbara; Hallek, Michael; Goede, Valentin
Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia
LEUKEMIA
IF13.4
2019-03-2517
OAAI
Jebaraj, Billy Michael Chelliah; Tausch, Eugen; Landau, Dan A.; Bahlo, Jasmin; Robrecht, Sandra; Taylor-Weiner, Amaro N.; Bloehdorn, Johannes; Scheffold, Annika; Mertens, Daniel; Boettcher, Sebastian; Kneba, Michael; Jaeger, Ulrich; Zenz, Thorsten; Wenger, Michael K.; Fingerle-Rowson, Guenter; Wendtner, Clemens; Fink, Anna-Maria; Wu, Catherine J.; Eichhorst, Barbara; Fischer, Kirsten; Hallek, Michael; Doehner, Hartmut; Stilgenbauer, Stephan
CLL2-BIG: sequential treatment with bendamustine, ibrutinib and obinutuzumab (GA101) in chronic lymphocytic leukemia
LEUKEMIA
IF13.4
2018-12-1940
PREAI
von Tresckow, Julia; Cramer, Paula; Bahlo, Jasmin; Robrecht, Sandra; Langerbeins, Petra; Fink, Anna-Maria; Al-Sawaf, Othman; Illmer, Thomas; Klaproth, Holger; Estenfelder, Sven; Ritgen, Matthias; Fischer, Kirsten; Wendtner, Clemens-Martin; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Boettcher, Sebastian; Eichhorst, Barbara F.; Hallek, Michael

研究方向

暂未获取到该数据
M
Michael Hallek
H 指数:124论文数:1,647被引数:7.1万
B
Barbara Eichhorst
H 指数:62论文数:438被引数:2.1万
K
Kirsten Fischer
H 指数:48论文数:389被引数:1.5万
S
Stephan Stilgenbauer
H 指数:126论文数:1,220被引数:7.3万
S
Sandra Robrecht
H 指数:30论文数:152被引数:3,813
P
Paula Cramer
H 指数:31论文数:177被引数:6,836
C
Clemens‐Martin Wendtner
H 指数:65论文数:436被引数:2.6万
P
Petra Langerbeins
H 指数:23论文数:111被引数:2,418
O
Othman Al‐Sawaf
H 指数:34论文数:184被引数:6,441
J
Julia von Tresckow
H 指数:20论文数:104被引数:2,783